摘要
目的探讨宫腔镜治疗黏膜下子宫肌瘤的临床疗效与安全性。方法对经B超与宫腔镜联合检查确诊为黏膜下子宫肌瘤的87例患者资料进行回顾性分析,87例患者均行经宫颈宫腔镜下肿瘤切除术,术后随访1~3年,从残余肌瘤再生情况、月经状况有无改善、是否需要二次手术分析手术疗效,从并发症发生情况分析手术安全性。结果 87例患者术中B超和宫腔镜检查、病理送检均证实为黏膜下子宫肌瘤,其中0型患者46例,Ⅰ型患者32例,Ⅱ型患者9例。术中术后无子宫出血、穿孔、水中毒等,安全性高。87例患者术后月经均有不同程度改善,无再次手术病例,残余肌瘤再生不显著,疗效肯定。结论宫腔镜治疗黏膜下子宫肌瘤具有高效、安全等优点,值得临床推广。
Objective Review the efficacy and safety of hysteroscopy operation in the treatment of submucosal myoma of uterus.Methods By B-type ultrasound and hysteroscopy combined with diagnosed submucosal myoma of uterus in 87 patients were retrospectively analyzed.87 cases were passing through the cervical hysteroscopic resection of the tumor,patients were followed up for 1 to 3 years from the regeneration of residual fibroids,menstrual status of any improvement,whether the need for secondary surgery,surgical safety for the analysis of complications.Results 87 patients were all confirmed of submucosal uterine fibroids by intraoperative B ultrasound、hysteroscopy and pathological inspection,46 cases of patients with type 0,32 cases of patients with typeⅠ,9 cases of patients with typeⅡ.Having no intraoperative and postoperative uterine bleeding,perforation,water intoxication cases,operation safety was high.87 cases of postoperative period were improved to some extent,reoperation cases residual fibroids regeneration was not significant,more effective.Conclusions hysteroscopic treatment of submucous uterine fibroids has the advantages of efficient,safe and worthy of promotion.
出处
《中国肿瘤临床与康复》
2012年第6期556-558,共3页
Chinese Journal of Clinical Oncology and Rehabilitation